サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1500809

トキソプラズマ症検査市場：世界の産業分析、規模、シェア、成長、動向、予測、2024年～2033年

Toxoplasmosis Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

出版日
ページ情報
英文 238 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
トキソプラズマ症検査市場：世界の産業分析、規模、シェア、成長、動向、予測、2024年～2033年
出版日: 2024年06月18日
発行: Persistence Market Research
ページ情報: 英文 238 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Research社はこのほど、世界のトキソプラズマ症検査市場に関する包括的なレポートを発表しました。当レポートでは、市場促進要因・動向・機会・課題を含む重要な市場力学を徹底的に評価し、市場構造に関する詳細な洞察を提供しています。

主な洞察

  • トキソプラズマ症検査の市場規模（2024E）：22億米ドル
  • 予測市場規模（2033F）：2億2,000万米ドル35億米ドル
  • 世界市場成長率（CAGR 2024年～2033年）：5.3%：5.3%

トキソプラズマ症検査市場：調査範囲

トキソプラズマ症検査は、寄生虫トキソプラズマ・ゴンディによる感染症の診断と管理において重要な役割を果たしています。これらの検査には、様々な臨床検体中の抗体や寄生虫自体の存在を検出することを目的とした血清学的アッセイ、分子診断、画像診断技術が含まれます。同市場は、病院、診療所、診断研究所、研究機関を対象としており、PCR、ELISA、画像診断など、さまざまな検査法を提供しています。

市場成長の促進要因：

世界のトキソプラズマ症検査市場は、トキソプラズマ症が特に妊娠中の女性や免疫不全患者にとって重大な健康上の懸念事項であるという認識の高まりなど、いくつかの重要な要因によって牽引されています。食習慣の変化やペットの飼育動向などの要因により、トキソプラズマ症感染の罹患率が上昇していることが、市場の拡大をさらに後押ししています。迅速分子アッセイや自動化プラットフォームの開発など、診断技術の技術的進歩が診断精度とワークフローの効率を高め、市場の成長を促進しています。さらに、ヘルスケア支出の拡大や、感染症管理の改善を目的とした政府の支援策が市場開拓に寄与しています。

市場抑制要因：

有望な成長が見込まれるもの、トキソプラズマ症検査市場は、特に新興国地域の農村部や十分なサービスを受けていない地域における検査施設へのアクセスに関する課題に直面しています。また、規制上のハードルやトキソプラズマ症検査法に対する償還政策の違いも、市場浸透の制約要因となっています。さらに、診断検査の精度に関する懸念や、多くの場合トキソプラズマ症感染の無症候性が、検査率や市場成長の可能性に影響を与えています。

市場機会：

トキソプラズマ症検査市場は、診断プラットフォームにおける技術革新、ヘルスケア啓発キャンペーンの増加、ポイントオブケア検査ソリューションの統合によって大きな成長機会がもたらされます。また、遠隔医療や遠隔診断サービスの採用は、特に地理的に分散した人々への市場リーチを拡大します。さらに、診断会社、ヘルスケアプロバイダー、公衆衛生機関が戦略的に協力し、検査の利用しやすさと購入しやすさを向上させることは、市場拡大にとって極めて重要です。

本レポートで扱う主な質問

  • 世界のトキソプラズマ症検査市場の成長を促進する主な要因は何か？
  • 異なるヘルスケア環境において、どの診断方法と技術がトキソプラズマ症検査の採用をリードしているか？
  • 技術の進歩はトキソプラズマ症検査市場の競合情勢をどのように変えているのか？
  • トキソプラズマ症検査市場に貢献している主要プレイヤーは誰であり、市場の関連性を維持するためにどのような戦略を採用しているのか？
  • 世界のトキソプラズマ症検査市場における新たな動向と将来性は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/ 分類
  • 市場の定義/ 範囲/ 制限
  • 含まれるもの/含まれないも

第3章 市場動向

  • 市場に影響を与える主な動向
  • 製品イノベーション/開発動向

第4章 付加価値の洞察

  • 製品採用分析
  • 製品使用状況分析
  • 規制の枠組み
  • 最近の製品承認/発売
  • ポーターの分析
  • バリューチェーン分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因- 関連性と影響
  • 市場力学

第6章 世界市場の需要（価値または規模）分析

  • 収益機会シナリオ-可能性が高い/保守的/楽観的
  • 2019年～2023年の市場金額の歴史的分析
  • 現在および将来の市場金額予測、2024年～2033年
    • 前年比成長動向分析
    • 絶対的な$機会分析

第7章 検査タイプ別の世界市場分析

  • イントロダクション/主な調査結果
  • 2019年～2023年における検査タイプ別の市場規模の歴史的分析
  • 現在および将来の市場規模分析と予測、検査タイプ別、2024年～2033年
    • 血清学的検査
      • 染料テスト
      • 間接赤血球凝集反応アッセイ
      • 直接凝集アッセイ
    • エリサ
    • PCR
    • 超音波
    • MRI
    • 生検
  • 検査タイプ別の市場の魅力分析

第8章 サンプル別世界市場分析

  • イントロダクション/主な調査結果
  • 過去の市場規模分析、サンプル別、2019年～2023年
  • 現在および将来の市場規模の分析と予測（サンプル別、2024年～2033年）
    • 血液サンプル
    • 羊水
    • 脳脊髄液
  • サンプルによる市場の魅力分析

第9章 エンドユーザー別世界市場分析

  • イントロダクション/主な調査結果
  • 過去の市場規模分析、エンドユーザー別、2019年～2023年
  • 現在および将来の市場規模の分析と予測、エンドユーザー別、2024年～2033年
    • 病院
    • クリニック
    • 診断検査室
  • エンドユーザー別市場の魅力分析

第10章 地域別世界市場分析

  • イントロダクション
  • 2019年～2023年における地域別市場規模の歴史的分析
  • 現在および将来の市場規模の地域別分析と予測、2024年～2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 南アジア
    • 東アジア
    • オセアニア
    • 中東・アフリカ
  • 地域別市場の魅力分析

第11章 北米市場分析

第12章 ラテンアメリカ市場分析

第13章 欧州市場分析

第14章 東アジア市場分析

第15章 南アジア市場分析

第16章 オセアニア市場分析

第17章 中東・アフリカ市場分析

第18章 市場構造分析

  • 企業階層別市場分析（マタニティケア製品）
  • 主要企業の市場シェア分析
  • 市場集中

第19章 競合分析

  • 競合ダッシュボード
  • 主要プレーヤーによるブランディングとプロモーション戦略
  • 主要開発分析
  • 競合の詳細
    • Abbott Laboratories
    • Bio-Rad Laboratories Inc
    • Affymetrix Inc.
    • Beckman Coulter Inc.
    • Biotest
    • Cepheid Inc.
    • GenBio
    • Danaher Corporation
    • Thermo Fisher Scientific
    • Biomerica Inc.
    • Biomerix

第20章 使用される仮定と頭字語

第21章 調査手法

目次
Product Code: PMRREP4289

Persistence Market Research has recently released a comprehensive report on the worldwide market for toxoplasmosis testing. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Toxoplasmosis Testing Market Size (2024E): USD 2.2 Billion
  • Projected Market Value (2033F): USD 3.5 Billion
  • Global Market Growth Rate (CAGR 2024 to 2033): 5.3%

Toxoplasmosis Testing Market - Report Scope:

Toxoplasmosis testing plays a crucial role in diagnosing and managing infections caused by the parasite Toxoplasma gondii. These tests include serological assays, molecular diagnostics, and imaging techniques aimed at detecting antibodies or the presence of the parasite itself in various clinical specimens. The market caters to hospitals, clinics, diagnostic laboratories, and research institutions, offering a range of testing methods such as PCR, ELISA, and imaging modalities.

Market Growth Drivers:

The global toxoplasmosis testing market is driven by several key factors, including increasing awareness about toxoplasmosis as a significant health concern, particularly for pregnant women and immunocompromised individuals. The rising incidence of toxoplasmosis infections, fueled by factors such as changing dietary habits and pet ownership trends, further propels market expansion. Technological advancements in diagnostic techniques, such as the development of rapid molecular assays and automated platforms, enhance diagnostic accuracy and workflow efficiency, driving market growth. Moreover, expanding healthcare expenditure and supportive government initiatives aimed at improving infectious disease management contribute to market development.

Market Restraints:

Despite promising growth prospects, the toxoplasmosis testing market faces challenges related to accessibility to testing facilities in rural and underserved areas, particularly in developing regions. Regulatory hurdles and varying reimbursement policies for toxoplasmosis testing procedures also pose constraints on market penetration. Additionally, concerns regarding the accuracy of diagnostic tests and the asymptomatic nature of toxoplasmosis infections in many cases impact testing rates and market growth potential.

Market Opportunities:

The toxoplasmosis testing market presents significant growth opportunities driven by technological innovations in diagnostic platforms, increasing healthcare awareness campaigns, and the integration of point-of-care testing solutions. The adoption of telemedicine and remote diagnostic services also broadens market reach, particularly in geographically dispersed populations. Furthermore, strategic collaborations between diagnostic companies, healthcare providers, and public health agencies to improve testing accessibility and affordability are crucial for market expansion.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the toxoplasmosis testing market globally?
  • Which diagnostic methods and technologies are leading the toxoplasmosis testing adoption across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the toxoplasmosis testing market?
  • Who are the key players contributing to the toxoplasmosis testing market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global toxoplasmosis testing market?

Competitive Intelligence and Business Strategy:

Leading players in the global toxoplasmosis testing market, including Roche Diagnostics, Thermo Fisher Scientific, and Bio-Rad Laboratories, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced diagnostic assays, expand their geographical presence, and enhance market penetration. Collaboration with healthcare providers, academic institutions, and regulatory bodies facilitates product approvals and market access, driving technological innovation and market growth.

Key Companies Profiled:

  • Abbott Laboratories
  • Bio-Rad Laboratories Inc
  • Affymetrix Inc.
  • Beckman Coulter Inc.
  • Biotest
  • Cepheid Inc.
  • GenBio
  • Danaher Corporation
  • Thermo Fisher Scientific
  • Biomerica Inc.
  • Biomerix

Key Segments of Toxoplasmosis Testing Industry Research

Test Type:

  • Serological Tests
  • ELISA
  • PCR
  • Ultrasound
  • MRI
  • Biopsy

Sample:

  • Blood Samples
  • Amniotic Fluid
  • Cerebrospinal Fluid

End User:

  • Hospitals
  • Clinics
  • Diagnostic Laboratories

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions/Exclusions

3. Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Value Added Insights

  • 4.1. Product Adoption Analysis
  • 4.2. Product Usage Analysis
  • 4.3. Regulatory Framework
  • 4.4. Recent Product Approvals/Launches
  • 4.5. Porter's Analysis
  • 4.6. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global Per Capita Healthcare Spending
    • 5.1.2. Global Life Expectancy Outlook
    • 5.1.3. Global Research and Development Funding Outlook
    • 5.1.4. Global Infectious Disease Testing Market (Parent Market Analysis)
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Increasing prevalence of toxoplasmosis
    • 5.2.2. Evolving healthcare policies and clinical guidelines
    • 5.2.3. Advancements in Diagnostic Technologies
    • 5.2.4. Research and Development
    • 5.2.5. Public Health Campaigns
    • 5.2.6. Pregnancy Care Emphasis
    • 5.2.7. Regulatory Approvals
    • 5.2.8. Patient Awareness and Education
    • 5.2.9. Emerging Healthcare Markets
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. Global Market Demand (in Value or Size in US$ Million) Analysis 2019-2023 and Forecast, 2024-2033

  • 6.1. Revenue Opportunity Scenario- Likely/Conservative/Optimistic
  • 6.2. Historical Market Value (US$ Million) Analysis, 2019-2023
  • 6.3. Current and Future Market Value (US$ Million) Projections, 2024-2033
    • 6.3.1. Y-o-Y Growth Trend Analysis
    • 6.3.2. Absolute $ Opportunity Analysis

7. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Test Type

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size (US$ Million) Analysis By Test Type, 2019-2023
  • 7.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Test Type, 2024-2033
    • 7.3.1. Serological Test
      • 7.3.1.1. Dye Test
      • 7.3.1.2. Indirect Hemagglutination Assay
      • 7.3.1.3. Direct agglutination Assay
    • 7.3.2. ELISA
    • 7.3.3. PCR
    • 7.3.4. Ultrasound
    • 7.3.5. MRI
    • 7.3.6. Biopsy
  • 7.4. Market Attractiveness Analysis By Test Type

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Sample

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Million) Analysis, By Sample, 2019-2023
  • 8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Sample, 2024-2033
    • 8.3.1. Blood Sample
    • 8.3.2. Amniotic Fluid
    • 8.3.3. Cerebrospinal Fluid
  • 8.4. Market Attractiveness Analysis By Sample

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Million) Analysis, By End User, 2019-2023
  • 9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2024-2033
    • 9.3.1. Hospitals
    • 9.3.2. Clinics
    • 9.3.3. Diagnostic Laboratories
  • 9.4. Market Attractiveness Analysis By End User

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Million) Analysis, By Region, 2019-2023
  • 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2024-2033
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. South Asia
    • 10.3.5. East Asia
    • 10.3.6. Oceania
    • 10.3.7. Middle East & Africa
  • 10.4. Market Attractiveness Analysis By Region

11. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 11.3.1. By Country
      • 11.3.1.1. United States
      • 11.3.1.2. Canada
    • 11.3.2. By Test Type
    • 11.3.3. By Sample
    • 11.3.4. By End User
  • 11.4. Market Attractiveness Analysis
    • 11.4.1. By Country
    • 11.4.2. By Test Type
    • 11.4.3. By Sample
    • 11.4.4. By End User
  • 11.5. Market Trends
  • 11.6. Market Drivers & Restraints - Impact Analysis
  • 11.7. Country Level Analysis & Forecast
    • 11.7.1. United States Market
      • 11.7.1.1. Introduction
      • 11.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 11.7.1.2.1. By Test Type
        • 11.7.1.2.2. By Sample
        • 11.7.1.2.3. By End User
    • 11.7.2. Canada Market
      • 11.7.2.1. Introduction
      • 11.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 11.7.2.2.1. By Test Type
        • 11.7.2.2.2. By Sample
        • 11.7.2.2.3. By End User

12. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 12.3.1. By Country
      • 12.3.1.1. Brazil
      • 12.3.1.2. Mexico
      • 12.3.1.3. Argentina
      • 12.3.1.4. Rest of LATAM
    • 12.3.2. By Test Type
    • 12.3.3. By Sample
    • 12.3.4. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Test Type
    • 12.4.3. By Sample
    • 12.4.4. By End User
  • 12.5. Market Trends
  • 12.6. Market Drivers & Restraints - Impact Analysis
  • 12.7. Country Level Analysis & Forecast
    • 12.7.1. Brazil Market
      • 12.7.1.1. Introduction
      • 12.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.7.1.2.1. By Test Type
        • 12.7.1.2.2. By Sample
        • 12.7.1.2.3. By End User
    • 12.7.2. Mexico Market
      • 12.7.2.1. Introduction
      • 12.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.7.2.2.1. By Test Type
        • 12.7.2.2.2. By Sample
        • 12.7.2.2.3. By End User
    • 12.7.3. Argentina Market
      • 12.7.3.1. Introduction
      • 12.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 12.7.3.2.1. By Test Type
        • 12.7.3.2.2. By Sample
        • 12.7.3.2.3. By End User

13. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. United Kingdom
      • 13.3.1.2. Germany
      • 13.3.1.3. France
      • 13.3.1.4. Italy
      • 13.3.1.5. Spain
      • 13.3.1.6. BENELUX
      • 13.3.1.7. Russia
      • 13.3.1.8. Rest of Europe
    • 13.3.2. By Test Type
    • 13.3.3. By Sample
    • 13.3.4. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Test Type
    • 13.4.3. By Sample
    • 13.4.4. By End User
  • 13.5. Market Trends
  • 13.6. Market Drivers & Restraints - Impact Analysis
  • 13.7. Country Level Analysis & Forecast
    • 13.7.1. United Kingdom Market
      • 13.7.1.1. Introduction
      • 13.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.7.1.2.1. By Test Type
        • 13.7.1.2.2. By Sample
        • 13.7.1.2.3. By End User
    • 13.7.2. Germany Market
      • 13.7.2.1. Introduction
      • 13.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.7.2.2.1. By Test Type
        • 13.7.2.2.2. By Sample
        • 13.7.2.2.3. By End User
    • 13.7.3. France Market
      • 13.7.3.1. Introduction
      • 13.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.7.3.2.1. By Test Type
        • 13.7.3.2.2. By Sample
        • 13.7.3.2.3. By End User
    • 13.7.4. Italy Market
      • 13.7.4.1. Introduction
      • 13.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 13.7.4.2.1. By Test Type
        • 13.7.4.2.2. By Sample
        • 13.7.4.2.3. By End User
    • 13.7.5. Spain Market
      • 13.7.5.1. Introduction
      • 13.7.5.2. Market Analysis and Forecast by Market Taxonomy
        • 13.7.5.2.1. By Test Type
        • 13.7.5.2.2. By Sample
        • 13.7.5.2.3. By End User
    • 13.7.6. BENELUX Market
      • 13.7.6.1. Introduction
      • 13.7.6.2. Market Analysis and Forecast by Market Taxonomy
        • 13.7.6.2.1. By Test Type
        • 13.7.6.2.2. By Sample
        • 13.7.6.2.3. By End User
    • 13.7.7. Russia Market
      • 13.7.7.1. Introduction
      • 13.7.7.2. Market Analysis and Forecast by Market Taxonomy
        • 13.7.7.2.1. By Test Type
        • 13.7.7.2.2. By Sample
        • 13.7.7.2.3. By End User

14. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. China
      • 14.3.1.2. Japan
      • 14.3.1.3. South Korea
    • 14.3.2. By Test Type
    • 14.3.3. By Sample
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Test Type
    • 14.4.3. By Sample
    • 14.4.4. By End User
  • 14.5. Market Trends
  • 14.6. Market Drivers & Restraints - Impact Analysis
  • 14.7. Country Level Analysis & Forecast
    • 14.7.1. China Market
      • 14.7.1.1. Introduction
      • 14.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.1.2.1. By Test Type
        • 14.7.1.2.2. By Sample
        • 14.7.1.2.3. By End User
    • 14.7.2. Japan Market
      • 14.7.2.1. Introduction
      • 14.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.2.2.1. By Test Type
        • 14.7.2.2.2. By Sample
        • 14.7.2.2.3. By End User
    • 14.7.3. South Korea Market
      • 14.7.3.1. Introduction
      • 14.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.3.2.1. By Test Type
        • 14.7.3.2.2. By Sample
        • 14.7.3.2.3. By End User

15. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Indonesia
      • 15.3.1.3. Thailand
      • 15.3.1.4. Malaysia
      • 15.3.1.5. Rest of South Asia
    • 15.3.2. By Test Type
    • 15.3.3. By Sample
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Test Type
    • 15.4.3. By Sample
    • 15.4.4. By End User
  • 15.5. Market Trends
  • 15.6. Market Drivers & Restraints - Impact Analysis
  • 15.7. Country Level Analysis & Forecast
    • 15.7.1. India Market
      • 15.7.1.1. Introduction
      • 15.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.1.2.1. By Test Type
        • 15.7.1.2.2. By Sample
        • 15.7.1.2.3. By End User
    • 15.7.2. Indonesia Market
      • 15.7.2.1. Introduction
      • 15.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.2.2.1. By Test Type
        • 15.7.2.2.2. By Sample
        • 15.7.2.2.3. By End User
    • 15.7.3. Thailand Market
      • 15.7.3.1. Introduction
      • 15.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.3.2.1. By Test Type
        • 15.7.3.2.2. By Sample
        • 15.7.3.2.3. By End User
    • 15.7.4. Malaysia Market
      • 15.7.4.1. Introduction
      • 15.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.4.2.1. By Test Type
        • 15.7.4.2.2. By Sample
        • 15.7.4.2.3. By End User

16. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. Australia
      • 16.3.1.2. New Zealand
    • 16.3.2. By Test Type
    • 16.3.3. By Sample
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Test Type
    • 16.4.3. By Sample
    • 16.4.4. By End User
  • 16.5. Market Trends
  • 16.6. Market Drivers & Restraints - Impact Analysis
  • 16.7. Country Level Analysis & Forecast
    • 16.7.1. Australia Market
      • 16.7.1.1. Introduction
      • 16.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.1.2.1. By Test Type
        • 16.7.1.2.2. By Sample
        • 16.7.1.2.3. By End User
    • 16.7.2. New Zealand Market
      • 16.7.2.1. Introduction
      • 16.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.2.2.1. By Test Type
        • 16.7.2.2.2. By Sample
        • 16.7.2.2.3. By End User

17. Middle East & Africa Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. GCC Countries
      • 17.3.1.2. Turkiye
      • 17.3.1.3. South Africa
      • 17.3.1.4. Northern Africa
      • 17.3.1.5. Rest of Middle East and Africa
    • 17.3.2. By Test Type
    • 17.3.3. By Sample
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Test Type
    • 17.4.3. By Sample
    • 17.4.4. By End User
  • 17.5. Market Trends
  • 17.6. Market Drivers & Restraints - Impact Analysis
  • 17.7. Country Level Analysis & Forecast
    • 17.7.1. GCC Countries Market
      • 17.7.1.1. Introduction
      • 17.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.1.2.1. By Test Type
        • 17.7.1.2.2. By Sample
        • 17.7.1.2.3. By End User
    • 17.7.2. Turkiye Market
      • 17.7.2.1. Introduction
      • 17.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.2.2.1. By Test Type
        • 17.7.2.2.2. By Sample
        • 17.7.2.2.3. By End User
    • 17.7.3. South Africa Market
      • 17.7.3.1. Introduction
      • 17.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.3.2.1. By Test Type
        • 17.7.3.2.2. By Sample
        • 17.7.3.2.3. By End User
    • 17.7.4. Northern Africa Market
      • 17.7.4.1. Introduction
      • 17.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.4.2.1. By Test Type
        • 17.7.4.2.2. By Sample
        • 17.7.4.2.3. By End User

18. Market Structure Analysis

  • 18.1. Market Analysis by Tier of Companies (Maternity Care Products)
  • 18.2. Market Share Analysis of Top Players
  • 18.3. Market Concentration

19. Competition Analysis

  • 19.1. Competition Dashboard
  • 19.2. Branding and Promotional Strategies, By key Players
  • 19.3. Key Development Analysis
  • 19.4. Competition Deep Dive
    • 19.4.1. Abbott Laboratories
      • 19.4.1.1. Overview
      • 19.4.1.2. Product Portfolio
      • 19.4.1.3. Key Financials
      • 19.4.1.4. SWOT Analysis
      • 19.4.1.5. Key Developments
      • 19.4.1.6. Sales Footprint
      • 19.4.1.7. Strategy Overview
        • 19.4.1.7.1. Marketing Strategy
        • 19.4.1.7.2. Product Strategy
        • 19.4.1.7.3. Channel Strategy
    • 19.4.2. Bio-Rad Laboratories Inc
      • 19.4.2.1. Overview
      • 19.4.2.2. Product Portfolio
      • 19.4.2.3. Key Financials
      • 19.4.2.4. SWOT Analysis
      • 19.4.2.5. Key Developments
      • 19.4.2.6. Sales Footprint
      • 19.4.2.7. Strategy Overview
        • 19.4.2.7.1. Marketing Strategy
        • 19.4.2.7.2. Product Strategy
        • 19.4.2.7.3. Channel Strategy
    • 19.4.3. Affymetrix Inc.
      • 19.4.3.1. Overview
      • 19.4.3.2. Product Portfolio
      • 19.4.3.3. Key Financials
      • 19.4.3.4. SWOT Analysis
      • 19.4.3.5. Key Developments
      • 19.4.3.6. Sales Footprint
      • 19.4.3.7. Strategy Overview
        • 19.4.3.7.1. Marketing Strategy
        • 19.4.3.7.2. Product Strategy
        • 19.4.3.7.3. Channel Strategy
    • 19.4.4. Beckman Coulter Inc.
      • 19.4.4.1. Overview
      • 19.4.4.2. Product Portfolio
      • 19.4.4.3. Key Financials
      • 19.4.4.4. SWOT Analysis
      • 19.4.4.5. Key Developments
      • 19.4.4.6. Sales Footprint
      • 19.4.4.7. Strategy Overview
        • 19.4.4.7.1. Marketing Strategy
        • 19.4.4.7.2. Product Strategy
        • 19.4.4.7.3. Channel Strategy
    • 19.4.5. Biotest
      • 19.4.5.1. Overview
      • 19.4.5.2. Product Portfolio
      • 19.4.5.3. Key Financials
      • 19.4.5.4. SWOT Analysis
      • 19.4.5.5. Key Developments
      • 19.4.5.6. Sales Footprint
      • 19.4.5.7. Strategy Overview
        • 19.4.5.7.1. Marketing Strategy
        • 19.4.5.7.2. Product Strategy
        • 19.4.5.7.3. Channel Strategy
    • 19.4.6. Cepheid Inc.
      • 19.4.6.1. Overview
      • 19.4.6.2. Product Portfolio
      • 19.4.6.3. Key Financials
      • 19.4.6.4. SWOT Analysis
      • 19.4.6.5. Key Developments
      • 19.4.6.6. Sales Footprint
      • 19.4.6.7. Strategy Overview
        • 19.4.6.7.1. Marketing Strategy
        • 19.4.6.7.2. Product Strategy
        • 19.4.6.7.3. Channel Strategy
    • 19.4.7. GenBio
      • 19.4.7.1. Overview
      • 19.4.7.2. Product Portfolio
      • 19.4.7.3. Key Financials
      • 19.4.7.4. SWOT Analysis
      • 19.4.7.5. Key Developments
      • 19.4.7.6. Sales Footprint
      • 19.4.7.7. Strategy Overview
        • 19.4.7.7.1. Marketing Strategy
        • 19.4.7.7.2. Product Strategy
        • 19.4.7.7.3. Channel Strategy
    • 19.4.8. Danaher Corporation
      • 19.4.8.1. Overview
      • 19.4.8.2. Product Portfolio
      • 19.4.8.3. Key Financials
      • 19.4.8.4. SWOT Analysis
      • 19.4.8.5. Key Developments
      • 19.4.8.6. Sales Footprint
      • 19.4.8.7. Strategy Overview
        • 19.4.8.7.1. Marketing Strategy
        • 19.4.8.7.2. Product Strategy
        • 19.4.8.7.3. Channel Strategy
    • 19.4.9. Thermo Fisher Scientific
      • 19.4.9.1. Overview
      • 19.4.9.2. Product Portfolio
      • 19.4.9.3. Key Financials
      • 19.4.9.4. SWOT Analysis
      • 19.4.9.5. Key Developments
      • 19.4.9.6. Sales Footprint
      • 19.4.9.7. Strategy Overview
        • 19.4.9.7.1. Marketing Strategy
        • 19.4.9.7.2. Product Strategy
        • 19.4.9.7.3. Channel Strategy
    • 19.4.10. Biomerica Inc.
      • 19.4.10.1. Overview
      • 19.4.10.2. Product Portfolio
      • 19.4.10.3. Key Financials
      • 19.4.10.4. SWOT Analysis
      • 19.4.10.5. Key Developments
      • 19.4.10.6. Sales Footprint
      • 19.4.10.7. Strategy Overview
        • 19.4.10.7.1. Marketing Strategy
        • 19.4.10.7.2. Product Strategy
        • 19.4.10.7.3. Channel Strategy
    • 19.4.11. Biomerix
      • 19.4.11.1. Overview
      • 19.4.11.2. Product Portfolio
      • 19.4.11.3. Key Financials
      • 19.4.11.4. SWOT Analysis
      • 19.4.11.5. Key Developments
      • 19.4.11.6. Sales Footprint
      • 19.4.11.7. Strategy Overview
        • 19.4.11.7.1. Marketing Strategy
        • 19.4.11.7.2. Product Strategy
        • 19.4.11.7.3. Channel Strategy

20. Assumptions and Acronyms Used

21. Research Methodology